509 related articles for article (PubMed ID: 10086663)
21. [Analysis of lymph node metastasis in the thoracic esophageal squamous cell carcinoma].
Zhu ZJ; Zhao YF; Hu Y; Chen LQ; Liu LX; Wu Z; Kou YL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):138-40. PubMed ID: 18646699
[TBL] [Abstract][Full Text] [Related]
22. Impact of lymph node involvement in T2 or T3 thoracic esophageal squamous cell carcinoma.
Shimada H; Okazumi S; Shiratori T; Akutsu Y; Matsubara H
Hepatogastroenterology; 2009; 56(93):1039-43. PubMed ID: 19760937
[TBL] [Abstract][Full Text] [Related]
23. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
24. [Recurrence pattern and prognosis of esophageal cancer following tumor resection].
Chen J; Sang M; Chen Y
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):293-5. PubMed ID: 10920988
[TBL] [Abstract][Full Text] [Related]
25. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
26. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
[TBL] [Abstract][Full Text] [Related]
27. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
28. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma.
Liu YP; Ma L; Wang SJ; Chen YN; Wu GX; Han M; Wang XL
Eur J Surg Oncol; 2010 Feb; 36(2):155-9. PubMed ID: 19854606
[TBL] [Abstract][Full Text] [Related]
30. The pattern of lymphatic metastases in superficial squamous cell carcinoma of the esophagus.
Gotohda N; Nishimura M; Yoshida J; Nagai K; Tanaka N
Hepatogastroenterology; 2005; 52(61):105-7. PubMed ID: 15783006
[TBL] [Abstract][Full Text] [Related]
31. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus.
Osugi H; Takemura M; Higashino M; Takada N; Lee S; Ueno M; Tanaka Y; Fukuhara K; Hashimoto Y; Fujiwara Y; Kinoshita H
Oncol Rep; 2003; 10(1):81-7. PubMed ID: 12469149
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma.
Dresner SM; Lamb PJ; Shenfine J; Hayes N; Griffin SM
Eur J Surg Oncol; 2000 Aug; 26(5):492-7. PubMed ID: 11016472
[TBL] [Abstract][Full Text] [Related]
33. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers.
Komori T; Doki Y; Kabuto T; Ishikawa O; Hiratsuka M; Sasaki Y; Ohigashi H; Murata K; Yamada T; Miyashiro I; Mano M; Ishiguro S; Imaoka S
J Surg Oncol; 2003 Jan; 82(1):19-27. PubMed ID: 12501165
[TBL] [Abstract][Full Text] [Related]
35. Esophageal cancer patients surviving 6 years after esophagectomy.
Tachibana M; Dhar DK; Kinugasa S; Yoshimura H; Fujii T; Shibakita M; Ohno S; Ueda S; Kohno H; Nagasue N
Langenbecks Arch Surg; 2002 Jun; 387(2):77-83. PubMed ID: 12111259
[TBL] [Abstract][Full Text] [Related]
36. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
[TBL] [Abstract][Full Text] [Related]
37. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
38. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection.
Igaki H; Kato H; Tachimori Y; Nakanishi Y
Surgery; 2003 Apr; 133(4):368-74. PubMed ID: 12717353
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
[TBL] [Abstract][Full Text] [Related]
40. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.
Makino Y; Yamanoi A; Kimoto T; El-Assal ON; Kohno H; Nagasue N
Am J Gastroenterol; 2000 May; 95(5):1294-300. PubMed ID: 10811342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
